The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(21)00025-5

PubMed Identifier: 33770513

Publication URI: http://europepmc.org/abstract/MED/33770513

Type: Journal Article/Review

Parent Publication: The Lancet Global Health

Issue: 5

ISSN: 2214-109X